Revance Therapeutics, Inc. (RVNC): Price and Financial Metrics
Revance Therapeutics, Inc. (RVNC)
Today's Latest Price: $25.96 USD
Updated Oct 28 11:02am
Add RVNC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RVNC Stock Summary
- RVNC's price/sales ratio is 3,370.12; that's higher than the P/S ratio of 99.67% of US stocks.
- With a year-over-year growth in debt of 555.11%, Revance Therapeutics Inc's debt growth rate surpasses 96.71% of about US stocks.
- As for revenue growth, note that RVNC's revenue has grown -84.27% over the past 12 months; that beats the revenue growth of only 1.55% of US companies in our set.
- If you're looking for stocks that are quantitatively similar to Revance Therapeutics Inc, a group of peers worth examining would be ADVM, AUPH, VTVT, CRMD, and GERN.
- RVNC's SEC filings can be seen here. And to visit Revance Therapeutics Inc's official web site, go to www.revance.com.
RVNC Stock Price Chart Interactive Chart >
RVNC Price/Volume Stats
| Current price | $25.96 | 52-week high | $34.62 |
| Prev. close | $26.03 | 52-week low | $11.78 |
| Day low | $25.01 | Volume | 97,057 |
| Day high | $26.10 | Avg. volume | 698,140 |
| 50-day MA | $27.16 | Dividend yield | N/A |
| 200-day MA | $22.80 | Market Cap | 1.71B |
Revance Therapeutics, Inc. (RVNC) Company Bio
Revance Therapeutics is a specialty biopharmaceutical company focused on the development, manufacturing and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic indications. The company was founded in 1999 and is based in Newark, California.
Loading social stream, please wait...